Literature DB >> 25521465

Quality of life in women who use pessaries for longer than 12 months.

Sandi Tenfelde1, Dina Tell, Tonya Nicole Thomas, Kimberly Kenton.   

Abstract

OBJECTIVES: Pessaries are an effective treatment for pelvic organ prolapse and urinary incontinence; however, few data exist describing long-term pessary use. Our aim was to describe symptom bother and quality of life (QoL) in women using pessaries for urinary incontinence and/or prolapse for at least 12 months.
METHODS: Consecutive women who met inclusion criteria were approached for this observational cross-sectional study. Wilson and Cleary's Health-Related Quality of Life Model guided the inclusion of biologic, functional, and individual factors that impact the health-related QoL. Consenting participants completed a generalized QoL index, the Center for Epidemiologic Depression Symptoms, Medical Outcomes Study Social Support Survey, and condition-specific measures; the Pelvic Floor Distress Inventory (PFDI-20-SF) and the Pelvic Floor Impact Questionnaire.
RESULTS: Fifty-six women, mean age 74.4 years (range, 47-89 years), completed the survey. Mean length of time for pessary use was 4.5 years (1-15 years). Most of the women (n = 31, 55.4%) returned to the clinic for pessary care every 3 months. There was no difference in generalized QoL nor condition-specific total PFDI-20 in women performing self-care versus routine follow-up. Almost one third (29%) of participants reported complications related to pessary use (eg, vaginal erosion), and 41%were considering surgical repair in the near future. Women who were considering surgery had higher PFDI-20 scores relating to more bothersome prolapse symptoms than those not considering surgery (Pelvic Organ Prolapse Distress Inventory 6, 33.91 vs 24.73, P = 0.03).
CONCLUSIONS: Pessaries can be used to control pelvic floor symptoms for extended periods. Complication rates in this study were lower than previously reported, even in women not doing self-care. Not surprisingly, women considering surgical intervention reported greater symptom bother despite pessary use.

Entities:  

Mesh:

Year:  2015        PMID: 25521465     DOI: 10.1097/SPV.0000000000000154

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  7 in total

1.  Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.

Authors:  Benjamin C Shayo; Gileard G Masenga; Vibeke Rasch
Journal:  Int Urogynecol J       Date:  2018-08-18       Impact factor: 2.894

2.  Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.

Authors:  Sophie Ramsay; Le Mai Tu; Cara Tannenbaum
Journal:  Int Urogynecol J       Date:  2016-02-12       Impact factor: 2.894

3.  Bilateral sacrospinous fixation without hysterectomy: 18-month follow-up.

Authors:  Mehmet Baki Şentürk; Hakan Güraslan; Yusuf Çakmak; Murat Ekin
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

Review 4.  What is known from the existing literature about self-management of pessaries for pelvic organ prolapse? A scoping review.

Authors:  Lucy Dwyer; Dawn Dowding; R Kearney
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

5.  Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.

Authors:  Lucy Dwyer; Carol Bugge; Suzanne Hagen; Kirsteen Goodman; Wael Agur; Melanie Dembinsky; Margaret Graham; Karen Guerrero; Christine Hemming; Aethele Khunda; Doreen McClurg; Lynn Melone; Ranee Thakar; Rohna Kearney
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

Review 6.  Patient-Centered Goals for Treatment of Pelvic Floor Disorders.

Authors:  Angela Dao; Gena Dunivan
Journal:  Curr Bladder Dysfunct Rep       Date:  2022-10-14

7.  Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.

Authors:  Nahid Radnia; Maryam Hajhashemi; Tahereh Eftekhar; Maryam Deldar; Taraneh Mohajeri; Samira Sohbati; Zinat Ghanbari
Journal:  J Med Life       Date:  2019 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.